home / stock / hcwb / hcwb news


HCWB News and Press, HCW Biologics Inc. From 10/19/21

Stock Information

Company Name: HCW Biologics Inc.
Stock Symbol: HCWB
Market: NASDAQ
Website: hcwbiologics.com

Menu

HCWB HCWB Quote HCWB Short HCWB News HCWB Articles HCWB Message Board
Get HCWB Alerts

News, Short Squeeze, Breakout and More Instantly...

HCWB - MIME, LBTYA and PTEN among after hour movers

Gainers: Green Plains Partners LP (NASDAQ:GPP) +8%. Akero Therapeutics AKRO +5%. Ramaco Resources (NASDAQ:METC) +4%. Mimecast Limited (NASDAQ:MIME) +3%. Liberty Global plc (NASDAQ:LBTYA) +3%. Losers: WD-40 Company WDFC -10%. Xiaobai Maimai (NASDAQ:HX) -4%. New Fortress Energy (...

HCWB - CEIX, CEI and RDHL among mid-day movers

Gainers: Camber Energy (NYSE:CEI) +27%. HCW Biologics (NASDAQ:HCWB) +21%. Fuel Tech (NASDAQ:FTEK) +23%. RedHill (NASDAQ:RDHL) +19%. Harmony (NASDAQ:HRMY) +15%. Ginkgo Bioworks (NYSE:DNA) +15%. Arqit Quantum (NASDAQ:ARQQ) +14%. AlloVir (NASDAQ:ALVR) +13%. ViewRay (NASDAQ:VRAY) +13%. Full Truck...

HCWB - Making a Penny Stocks Watchlist? Don't Forget These 3 Small-Caps

3 Penny Stocks to Add to Your October Watchlist Right Now If you’re making a list of penny stocks to buy in October, there are a few things to keep in mind. For one, those investing in penny stocks need to have a thorough understanding of the current state of the stock market...

HCWB - HCW Biologics Showcases Scientific Paper in Molecular Therapy Highlighting Potential of HCW9218 as Novel, Bifunctional Cancer Immunotherapeutic

Lead Drug Candidate Engineered Using Tissue FactOr-Based FusIon (TOBI™) Platform Preclinical Data Demonstrated HCW9218 Antitumor Activity as Single-Agent Monotherapy and as an Adjunct to Enhance Potency of Therapeutic Antibodies Investigational New Drug Applic...

HCWB - HCW Biologics' Article Published in Cancer Immunology Research Validates Novel Tissue Factor Scaffold Fusion Protein (TOBI(TM)) Discovery Platform

TOBI™ Discovery Platform Creates GMP-Scale Heteromeric Fusion Protein Complexes (HFPCs) That Solve Issues with Multi-Signal Receptor Engagement on Immune Cells MIRAMAR, Fla., Aug. 17, 2021 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (NASDAQ: HCWB), an innovative biop...

HCWB - HCW Biologics Reports Second Quarter Financial Results and Recent Business Highlights

MIRAMAR, Fla., Aug. 13, 2021 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB), an innovative, biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade in...

HCWB - The IPO Recap - Party Is Everything But Over

Last week’s 19 IPO week had a lot of life sciences and software. This week, US IPO activity continues at a record with 25 scheduled IPOs, marking the fifth week in 2021 with at least 17 US IPOs, the most since 2000. With the August lull just around the corner, five SPACs raised $895....

HCWB - U.S. IPO Weekly Recap: Life Sciences, Software, And More Ride The Summer Wave In A 19 IPO Week

IPO activity continued at a record pace this past week with 19 IPOs, marking the fourth week in 2021 with at least 17 US IPOs, the most since the year 2000. With the August lull around the corner, the pipeline saw less activity than usual; five IPOs and 13 SPACs submitted initial fili...

HCWB - HCW Biologics Inc. Announces Closing of $56.0 Million Initial Public Offering

MIRAMAR, Fla., July 22, 2021 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (NASDAQ:HCWB) (the "Company"), an innovative preclinical stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade ...

Previous 10 Next 10